Most Commonly Denied CPT Codes in Ophthalmology

Ophthalmology billing presents unique reimbursement challenges because eye care combines medical exams, diagnostic imaging, surgical procedures, injections, drug billing, and vision-related services. Many ophthalmology practices also serve a high Medicare population, which increases the importance of medical necessity, documentation, modifier accuracy, and payer-specific policy compliance.

Because of this complexity, certain ophthalmology CPT® codes appear more frequently in denial reports than others. Understanding which services are commonly associated with claim denials can help ophthalmologists, practice administrators, and billing teams better evaluate reimbursement trends and payer behavior.

Why Ophthalmology Claims Receive Increased Payer Scrutiny

Ophthalmology practices frequently bill services that involve specialized diagnostic testing, laterality, drug administration, surgical global periods, and multiple services during the same encounter. A single patient visit may include an eye exam, OCT imaging, fundus photography, an injection, and a drug code, each with its own billing rules.

Payers often evaluate whether each service was medically necessary, separately reportable, properly documented, and not bundled into another service. These reviews can become especially complex when diagnostic tests are performed on the same day as procedures or when an office visit is billed with a minor procedure.

Because payer expectations can vary by plan, specialty, and service type, ophthalmology practices need a consistent process for aligning claims with payer policy requirements before denials occur.

Ophthalmology CPT® Codes Commonly Associated with Denials

While denial patterns vary by payer, patient population, and practice type, several ophthalmology procedures consistently appear among services most frequently associated with claim review and denial activity.

These procedures frequently appear in denial reports because they involve specialized coverage rules, diagnostic testing limitations, or same-day service combinations that require precise documentation and coding.

CPT® 92014 – Comprehensive Established Patient Eye Exam

CPT® 92014 is used for a comprehensive ophthalmological service for an established patient. It may include a complete eye examination, medical evaluation, initiation or continuation of diagnostic and treatment programs, and related clinical decision-making.

Why CPT® 92014 May Be Denied

This code can become denial-prone when payers question whether the documentation supports a comprehensive ophthalmological service rather than an E/M service or a lower-level eye code. Ophthalmology practices must also be careful when billing 92014 on the same date as a procedure, such as an intravitreal injection or laser service.

Same-day visit and procedure scenarios often create modifier -25 scrutiny. Payers may deny the exam if documentation does not support a significant, separately identifiable evaluation beyond the work already included in the procedure.

CPT® 92012 – Intermediate Established Patient Eye Exam

CPT® 92012 represents an intermediate ophthalmological service for an established patient. This code is commonly used for patients who require medical evaluation and treatment but do not meet the documentation requirements for a comprehensive exam.

Why CPT® 92012 May Be Denied

Claims involving CPT® 92012 may be denied when documentation does not clearly support the level of service billed or when the visit appears bundled into another same-day procedure. This is especially relevant in retina and glaucoma practices, where established patients may receive both medical evaluation and procedural treatment during the same encounter.

When ophthalmology teams decide between exam code families, documentation should support both the clinical work performed and the billing path selected. This is especially important when practices are choosing between E/M and eye codes for ophthalmology billing.

CPT® 92133 – OCT Optic Nerve

CPT® 92133 is used for scanning computerized ophthalmic diagnostic imaging of the posterior segment with interpretation and report, focused on the optic nerve. It is commonly associated with glaucoma, glaucoma suspect monitoring, optic nerve disorders, and related conditions.

Why CPT® 92133 May Be Denied

This code often receives payer scrutiny because repeat testing must be supported by diagnosis, clinical findings, disease progression, or monitoring needs. Claims may be denied when documentation does not clearly support why optic nerve imaging was medically necessary for the patient’s condition.

OCT optic nerve claims may also face issues when billed with other ophthalmic imaging codes that payers view as duplicative or bundled during the same encounter.

CPT® 92134 – OCT Retina

CPT® 92134 is used for scanning computerized ophthalmic diagnostic imaging of the posterior segment with interpretation and report, focused on the retina. It is commonly used for macular degeneration, diabetic retinopathy, macular edema, retinal vascular disease, and other posterior segment pathology.

Why CPT® 92134 May Be Denied

Because OCT retina testing is widely used in ophthalmology and retina practices, payers often monitor frequency, diagnosis support, and documentation of medical necessity. Repeated OCT testing may be questioned if the record does not clearly explain disease monitoring, treatment response, or clinical change.

Another common denial issue occurs when OCT retina and fundus photography are billed during the same encounter. Payers may apply strict National Correct Coding Initiative (NCCI) bundling edits unless documentation supports that both services were medically necessary and clinically distinct. In some cases, practices may need to append modifier -59 or payer-specific alternatives such as modifier -XU to demonstrate that each test addressed a separate condition, finding, or clinical purpose.

CPT® 92250 – Fundus Photography

CPT® 92250 represents fundus photography with interpretation and report. This service is commonly used to document diabetic eye disease, retinal lesions, optic nerve abnormalities, macular degeneration, and other posterior segment findings.

Why CPT® 92250 May Be Denied

Fundus photography claims are often denied when documentation does not clearly support why photographic documentation was necessary in addition to the eye exam or other imaging services. When fundus photography is billed with OCT, payers frequently apply strict NCCI bundling edits and may review whether the services were duplicative or whether each test answered a distinct clinical question. Documentation should clearly demonstrate why both studies were medically necessary and what unique clinical information each test provided.

Because fundus photography and OCT can overlap in how they document posterior segment disease, practices should expect these claims to receive payer attention when billed together.

CPT® 67028 – Intravitreal Injection

CPT® 67028 is used to report intravitreal injection of a pharmacologic agent. It is commonly performed in retina practices for conditions such as wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other retinal diseases requiring anti-VEGF or other injectable therapy.

Why CPT® 67028 May Be Denied

Intravitreal injection claims can be vulnerable to denial when the procedure code, drug code, diagnosis, and laterality do not align. Because these services often involve both a procedure and a high-cost medication, payers carefully review whether the documentation supports the medication administered, the eye treated, and the condition being managed.

Another frequent issue involves same-day office visits. When an exam is billed with an intravitreal injection, payers may deny the visit unless modifier -25 is properly applied and supported by documentation showing a separately identifiable evaluation.

Drug Billing Connected to Intravitreal Injection Claims

Although drug billing may involve HCPCS rather than CPT® codes, injectable ophthalmic medications are a major source of reimbursement risk for eye care practices. Anti-VEGF medications and other retinal therapies often carry high acquisition costs, which means payer denials can have an immediate financial impact.

Denials may occur when the units billed do not match the medication administered, when wastage documentation is incomplete—including the proper use of modifier -JW to report discarded amounts from single-dose containers—or when the diagnosis does not support the drug selected, or payer policy requires step therapy or prior authorization.

Because CPT® 67028 and the associated drug code are often adjudicated together, both pieces of the claim must tell the same clinical and billing story.

CPT® 66984 – Cataract Surgery with Intraocular Lens

CPT® 66984 is used for extracapsular cataract removal with insertion of an intraocular lens prosthesis. Cataract surgery is one of the most common ophthalmic surgical procedures and a major revenue driver for many practices.

Why CPT® 66984 May Be Denied

Because cataract surgery involves surgical documentation, visual function, medical necessity, and postoperative global period rules, payers often review these claims carefully. Denials may occur when documentation does not adequately support visual impairment, functional limitations, or the medical necessity of surgery.

Claims involving CPT® 66984 may also face issues when postoperative visits, unrelated services, or complications are billed during the global period without appropriate modifier support.

CPT® 65855 – Selective Laser Trabeculoplasty

CPT® 65855 is used to report selective laser trabeculoplasty, commonly performed for glaucoma management. Because glaucoma care often involves recurring exams, diagnostic testing, medications, and procedures, payers may closely review whether the procedure is supported by the patient’s diagnosis and treatment history.

Why CPT® 65855 May Be Denied

Denials involving CPT® 65855 may occur when documentation does not clearly support glaucoma severity, prior treatment attempts, intraocular pressure concerns, or the clinical rationale for laser intervention.

Global period and same-day visit rules may also affect reimbursement when an exam or diagnostic test is billed near the laser procedure.

CPT® 92015 – Refraction

CPT® 92015 is used to report determination of refractive state. Refraction is one of the most common services performed in eye care, but it is also one of the most common sources of patient billing confusion.

Why CPT® 92015 May Be Denied

Many medical plans do not cover routine refraction, even when the patient is receiving a medically necessary eye exam. As a result, claims involving CPT® 92015 may be denied as non-covered or processed as patient responsibility. Medicare generally considers refraction a non-covered service, making patient responsibility a common source of confusion and claim inquiries.

Although refraction denials may not always indicate coding error, they can create front-desk friction, patient complaints, and avoidable follow-up work when financial responsibility is not clearly communicated.

CPT® 76514 – Corneal Pachymetry

CPT® 76514 is used to report corneal pachymetry, or measurement of corneal thickness. This test is commonly associated with glaucoma evaluation, corneal disease, refractive surgery assessment, and certain anterior segment conditions.

Why CPT® 76514 May Be Denied

Payers may deny pachymetry claims when diagnosis support is unclear, when the service is repeated more frequently than expected, or when documentation does not explain why corneal thickness measurement was necessary for patient management.

Because pachymetry is often performed alongside other glaucoma-related services, it may also be reviewed in relation to broader diagnostic testing patterns.

Common Ophthalmology Denial Drivers

Ophthalmology claim denials often reflect the specialty’s mix of medical care, diagnostic testing, surgical procedures, and drug administration. Before a practice can understand denial trends, it helps to recognize recurring categories that appear across payer reports.

• Eye code versus E/M selection: Denials may occur when documentation does not clearly support the code family or level of service billed.
• Same-day exam and procedure issues: Office visits billed with injections, lasers, or other procedures may require modifier -25 support.
• Diagnostic imaging frequency limitations: OCT, fundus photography, and other tests may be reviewed when repeated frequently.
• Bundling edits: Payers may deny services such as OCT and fundus photography when billed together without distinct clinical support.
• Laterality errors: Eye-specific services may deny when RT, LT, or bilateral reporting does not match documentation.
• Global surgery period issues: Postoperative care and unrelated services must be billed carefully during global periods.
• Drug billing inconsistencies: Intravitreal injections may deny when procedure, drug, units, diagnosis, and eye treated do not align.

These denial drivers can overlap. For example, a retina claim may include an eye exam, OCT, intravitreal injection, and drug code on the same date. If documentation, modifiers, diagnosis codes, and laterality are not aligned, multiple denial risks can appear on one encounter.

Modifiers Frequently Associated with Ophthalmology Claim Denials

Modifier usage is another common source of reimbursement challenges in ophthalmology. The following modifiers frequently appear in denied or adjusted eye care claims.

Because ophthalmology encounters often involve exams, imaging, procedures, and medications performed during the same episode of care, modifier accuracy remains an important component of claim adjudication.

The Role of Medical Necessity in Ophthalmology Claims

Medical necessity remains one of the most significant factors influencing ophthalmology claim outcomes. Even when a service is clinically appropriate, reimbursement often depends on whether payer-specific policies support the exam, imaging test, injection, laser, or surgery performed.

Many ophthalmology services require documentation that connects diagnosis, visual symptoms, exam findings, imaging results, disease progression, laterality, and treatment decisions to the service billed. This is especially important for OCT imaging, fundus photography, glaucoma procedures, cataract surgery, and retina injections.

Strong ophthalmology billing workflows depend on records that clearly show why a service was needed, how it supported patient care, and why it met payer requirements for medical necessity documentation.

Diagnostic Imaging and Bundling Challenges

Diagnostic imaging is central to ophthalmology, but it also creates recurring denial risk. Tests such as OCT optic nerve, OCT retina, fundus photography, pachymetry, visual fields, and retinal imaging may be performed frequently for chronic disease monitoring.

Payers may deny imaging claims when tests are repeated more often than policy allows, when diagnosis support is unclear, or when two tests appear to provide overlapping information. OCT and fundus photography combinations are a common example because both may document posterior segment disease, but they do not always answer the same clinical question.

When payer systems identify bundled or overlapping services, claims may be denied unless documentation supports the distinct medical purpose of each test.

Global Surgery Period Challenges

Ophthalmology practices routinely manage procedures with global periods, including cataract surgery, glaucoma procedures, and retina surgeries. During these periods, certain postoperative care is considered included in the surgical payment.

Denials may occur when a visit or procedure is billed during the global period and payer systems interpret it as related to the original surgery. In some cases, the service may be unrelated or separately reportable, but the claim requires accurate modifier use and documentation that clearly explains the relationship to the prior procedure.

Global period denials can be especially frustrating because they may involve clinically appropriate care that fails payer adjudication due to documentation or modifier gaps.

The Financial Impact of Ophthalmology Claim Denials

Denied ophthalmology claims can affect more than reimbursement timelines. They create administrative burdens that require additional staff resources, appeals processing, payer communication, chart review, and claim follow-up.

For eye care practices, denial management can be especially costly because many denied claims involve diagnostic testing, surgery, or injectable medications. A denied exam may create administrative rework, but a denied drug or surgical claim can create a much larger financial impact.

Without clear reporting, these patterns can remain hidden across payers, providers, and procedure types. Better visibility through medical billing data analytics and reporting tools can help practices identify where reimbursement is breaking down and which denial categories deserve attention first.

Understanding Denial Trends Through Data Analysis

One of the most effective ways to understand ophthalmology denial patterns is through ongoing analysis of denial data. Tracking denials by CPT® code, payer, provider, location, diagnosis category, procedure type, modifier, and denial reason can reveal important reimbursement trends.

For example, a practice may discover that OCT denials are concentrated around one payer’s frequency policy, while intravitreal injection denials are tied to drug code mismatches or laterality errors. Another practice may find that modifier -25 denials are concentrated on same-day exam and injection encounters.

As payer policies continue to evolve, denial analytics have become increasingly important for healthcare organizations seeking to understand reimbursement challenges and recurring claim issues. A stronger process for managing rejected claims can also help billing teams respond faster when payer patterns begin to repeat.

Final Thoughts

Ophthalmology reimbursement is complex because the specialty spans medical exams, diagnostic testing, injections, drug billing, surgical procedures, global periods, and vision-related services. Each of these categories may be governed by different payer rules, documentation expectations, and modifier requirements.

CPT® codes including 92014, 92012, 92133, 92134, 92250, 67028, 66984, 65855, 92015, and 76514 frequently appear among ophthalmology services associated with claim denials because they involve payer scrutiny around medical necessity, bundling, same-day procedures, laterality, global periods, and coverage interpretation.

As payer policies continue to evolve, maintaining visibility into denial trends will remain an important part of ophthalmology revenue cycle management. Understanding which services are most commonly associated with denials can help practices evaluate reimbursement patterns, identify recurring claim issues, and strengthen billing performance over time.

Trademark notice: CPT is a registered trademark of the American Medical Association.

For informational purposes only.